Skip to main content

Published works by Dan Spivey

LEX-AR-HCCGPRKE · complete body of work · page 1 of 2 · 39 works

Published works

UK Medical Device Update: Developments in AI, Proposed GB Licensing Framework and Indefinite CE Mark Recognition
Covington Digital Health · October 21, 2026
LEX-WK-TRP57JHD
UK Medical Device Update: Developments in AI, Proposed GB Licensing Framework and Indefinite CE Mark Recognition
Inside EU Life Sciences · October 21, 2026
LEX-WK-0K8Q1WJX
New UK Guidance Clarifies Medical Device Status of AI Scribes
Global Policy Watch · August 17, 2026
LEX-WK-0QYSQ416
New UK Guidance Clarifies Medical Device Status of AI Scribes
Covington Digital Health · August 6, 2026
LEX-WK-TRNW8TQP
New UK Guidance Clarifies Medical Device Status of AI Scribes
Inside EU Life Sciences · August 6, 2026
LEX-WK-2E3921W6
U.S.–UK Pharmaceutical Pricing Agreement: Learnings from the Published Text
Inside EU Life Sciences · May 8, 2026
LEX-WK-TS4YCKBM
European Commission Adopts Proposal for the Biotech Act
Inside EU Life Sciences · December 17, 2025
LEX-WK-XSJ0FGTQ
The Proposed EU Biotech Act Aims to Accelerate and Streamline Procedures for the Approval of Clinical Trials and Combined Studies
Inside EU Life Sciences · December 17, 2025
LEX-WK-9R6AQ705
European Commission Announces (Long Awaited) Proposal to Simplify EU Medical Device Regulations
Inside EU Life Sciences · December 16, 2025
LEX-WK-V63KB53J
Landmark UK-US Pharmaceutical Deal
Global Policy Watch · December 5, 2025
LEX-WK-KMD8BRF0
Landmark UK-US Pharmaceutical Deal
Inside EU Life Sciences · December 2, 2025
LEX-WK-NA0ZRF90
MHRA Issues Statement of Policy Intent Regarding Early Access to Innovative Medical Devices
Global Policy Watch · August 14, 2025
LEX-WK-GMWD252C
MHRA Issues Statement of Policy Intent Regarding Early Access to Innovative Medical Devices
Inside EU Life Sciences · August 13, 2025
LEX-WK-SYYZT85D
MHRA Announces Consultation Response on Reforms to GB Pre-Market Medical Device Regulation
Global Policy Watch · July 31, 2025
LEX-WK-8F61T7GA
MHRA Announces Consultation Response on Reforms to GB Pre-Market Medical Device Regulation
Inside EU Life Sciences · July 30, 2025
LEX-WK-D23T3FGY
The Updated NHS Commercial Framework for New Medicines
Inside EU Life Sciences · March 3, 2025
LEX-WK-AGRYWJCX
Re-Launch of UK’s Innovative Licensing and Access Pathway (“ILAP”)
Inside EU Life Sciences · February 14, 2025
LEX-WK-5VKJ2K7Z
MHRA Consultation on Individualised mRNA Cancer Immunotherapies – Unique opportunity for a streamlined risk based regulatory framework?
Global Policy Watch · February 13, 2025
LEX-WK-P7475PGN
MHRA Consultation on Individualised mRNA Cancer Immunotherapies – Unique opportunity for a streamlined risk based regulatory framework?
Inside EU Life Sciences · February 12, 2025
LEX-WK-HNEQ9VGV
European Commission Consults on Update to Pharmacovigilance Rules
Inside EU Life Sciences · January 9, 2025
LEX-WK-MS89D590
Are you Windsor Framework ready? A focus on pharmaceutical supply chains and promotional material
Inside EU Life Sciences · December 18, 2024
LEX-WK-S3ANGQC2
MHRA Consults on New UK Pre-Market Medical Device Measures
Global Policy Watch · December 2, 2024
LEX-WK-ZDAF5K3X
MHRA Consults on New UK Pre-Market Medical Device Measures
Inside EU Life Sciences · November 28, 2024
LEX-WK-5ZJPD1T9
UK’s Medical Device Post-market Surveillance Statutory Instrument Laid Before Parliament – What are the Key Changes for Medical Device Regulation?
Global Policy Watch · October 28, 2024
LEX-WK-05ZHC469
UK’s Medical Device Post-market Surveillance Statutory Instrument Laid Before Parliament – What are the Key Changes for Medical Device Regulation?
Inside EU Life Sciences · October 28, 2024
LEX-WK-B3RMZ8TJ